Integrated pharmacokinetic–pharmacodynamic modeling to evaluate empiric carbapenem therapy in bloodstream infections

Integrated pharmacokinetic–pharmacodynamic modeling to evaluate empiric carbapenem therapy in bloodstream infections

10.2147/IDR.S168191

Saved in:

Bibliographic Details
Main Authors:	Lim, T.-P., Wang, R., Poh, G.Q., Koh, T.-H., Tan, T.-Y., Lee, W., Teo, J.Q.-M., Cai, Y., Tan, T.-T., Ee, P.L.R., Kwa, A.L.
Other Authors:	PHARMACY
Format:	Article
Published:	Dove Medical Press Ltd. 2021
Subjects:	Bloodstream infections Empiric carbapenem regimens Gram-negative bacteria Multidrug resistant
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/212640
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

In vitro activity of doripenem and other carbapenems against contemporary Gram-negative pathogens isolated from hospitalised patients in the Asia-Pacific region: Results of the COMPACT Asia-Pacific Study
by: Christiansen, K.J., et al.
Published: (2016)

The role of hospital environment in transmissions of multidrug-resistant gram-negative organisms
by: Chia, P.Y., et al.
Published: (2021)

Population Pharmacokinetics/Pharmacodynamics and Clinical Outcomes of Carbapenems in Critically Ill Patients
by: Apinya Boonpeng
Published: (2022)

Carbapenems and subsequent multiresistant bloodstream infection: does treatment duration matter?
by: Donaldson, A.D., et al.
Published: (2014)

The role of hospital environment in transmissions of multidrug-resistant gram-negative organisms
by: Chia, Po Ying, et al.
Published: (2021)

Treatment of extensively drug-resistant Gram-negative infections in critically ill patients: Outcome of a consensus meeting at the 13th Asia-Pacific Congress of Clinical Microbiology and Infection, October 2012
by: Tambyah, P.A., et al.
Published: (2016)

A potent host defense peptide triggers DNA damage and Is active against multidrug-resistant gram-negative pathogens
by: Juliano, Samuel A., et al.
Published: (2020)

Antecedent carbapenem exposure as a risk factor for non-carbapenemase-producing carbapenem-resistant enterobacteriaceae and carbapenemase-producing enterobacteriaceae
by: Marimuthu, Kalisvar, et al.
Published: (2020)

In vitro activity of biapenem and comparators against multidrug-resistant and carbapenem-resistant Acinetobacter baumannii isolated from tertiary care hospitals in Thailand
by: Jantana Houngsaitong, et al.
Published: (2020)

Using an adenosine triphosphate bioluminescent assay to determine effective antibiotic combinations against carbapenem-resistant gram negative bacteria within 24 hours
by: Cai Y., et al.
Published: (2019)

MULTIDRUG RESISTANT GRAM NEGATIVE ORGANISMS: EPIDEMIOLOGY AND OUTCOMES IN THE ICU
by: ANUPAMA VASUDEVAN
Published: (2015)

In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore
by: Lim, T.-P., et al.
Published: (2015)

Risk factors for adverse outcomes and multidrugresistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital
by: Poon, L.M., et al.
Published: (2016)

PREVALENCE, PREDICTORS AND OUTCOMES OF CENTRAL LINE-ASSOCIATED BLOODSTREAM INFECTIONS AMONG PATIENTS RECEIVING HAEMATOPOIETIC STEM CELL TRANSPLANT
by: TAN PIN YAN @TAN LI LING
Published: (2019)

Improving empiric antibiotic prescribing in pediatric bloodstream infections: a potential application of weighted-incidence syndromic combination antibiograms (WISCA)
by: Cook, Aislinn, et al.
Published: (2021)

In vitro pharmacodynamic syudies of B-lactam-B-lactamase inhibitor combinations against B-lactamase producing clinically important gram-negative bacteria
by: Duangkamon Amonsaksopon
Published: (2009)

Identification of bacteria harboring transglutaminase gene and its cloning and expression in Escherichia coli
by: Suwannee Khunthongpan
Published: (2023)

Once-daily intraperitoneal gentamicin is effective therapy for gram-negative CAPD peritonitis
by: Lye, W.-C., et al.
Published: (2014)

Treatment and Outcomes of Infections Caused by Diverse Carbapenemase-Producing Carbapenem-Resistant Enterobacterales
by: Lim, F.K., et al.
Published: (2021)

Prevalence and genotypic relatedness of carbapenem resistance among multidrug-resistant P. aeruginosa in tertiary hospitals across Thailand
by: Piyatip Khuntayaporn, et al.
Published: (2017)

Prospective audit of Febrile neutropenia management at a tertiary university hospital in Singapore
by: Jin, J., et al.
Published: (2014)

The role of allogeneic SCT in primary myelofibrosis: A British Society for Blood and Marrow Transplantation study
by: Stewart, W.A., et al.
Published: (2016)

Aeromonas dhakensis: clinical isolates with high carbapenem resistance
by: Puah, Suat Moi, et al.
Published: (2023)

Predictors and outcomes of healthcare-associated infections caused by carbapenem-nonsusceptible enterobacterales: a parallel matched case-control study
by: Hoo, Grace S. R., et al.
Published: (2023)

Comparative in-vitro study of killing activities and morphological changes of Cefpirome, Cefepime, Imipenem and Meropenem alone and in combination against gram negative bacteria
by: Phisit Khemawoot
Published: (2009)

Thrombin-Derived Host-Defense Peptides Modulate Monocyte/Macrophage Inflammatory Responses to Gram-Negative Bacteria
by: Hansen, Finja C., et al.
Published: (2017)

From Bench-Top to Bedside: A prospective In vitro Antibiotic Combination Testing (iACT) service to guide the selection of rationally optimized antimicrobial combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB)
by: Cai Y., et al.
Published: (2020)

Multiresistant Gram-negative infections: A global perspective
by: Ho, J., et al.
Published: (2016)

Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections caused by AmpC β-lactamase-producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens : a pilot multicenter randomized controlled trial (MERINO-2)
by: Stewart, Adam G., et al.
Published: (2021)

In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against Carbapenem-resistant Acinetobacter baumannii in Singapore
by: Lim T.-P., et al.
Published: (2019)

Value of intensive follow-up of patients after curative surgery for gastric carcinoma
by: Ing, T.T., et al.
Published: (2011)

Evaluation of in vitro bactericidal activity of aminoglycosides, fluoroquinolone and beta-lactam on gram negative pathogen
by: Kingkan Phanumass
Published: (2008)

Adult idiopathic thrombocytopenic purpura (ITP) - A prospective tracking of its natural history
by: Kueh, Y.K.
Published: (2014)

Oligopolyphenylenevinylene-conjugated oligoelectrolyte membrane insertion molecules selectively disrupt cell envelopes of gram-positive bacteria
by: Hinks, J, et al.
Published: (2020)

Functionalization of thermoswitchable liposomes for rapid detection of Gram-negative bacteria
by: Tan, Jie Ren, et al.
Published: (2022)

Emergence of Klebsiella pneumoniae co-producing NDM-type and OXA-181 carbapenemases
by: Balm, M.N.D., et al.
Published: (2016)

Synergistic Effects of Meropenem in Combination with Aminoglycosides against Carbapenem-Resistant Escherichia coli Harboring Extended-Spectrum Beta-Lactamase and Carbapenemase Genes
by: Pawarisa Terbtothakun
Published: (2023)

OXA-181-producing Klebsiella pneumoniae establishing in Singapore
by: Balm, M.N.D., et al.
Published: (2016)

The excess financial burden of multidrug resistance in severe gram-negative infections in Singaporean hospitals
by: Ng, E., et al.
Published: (2014)

Snake venom phospholipases A2: A novel tool against bacterial diseases
by: Samy, R.P., et al.
Published: (2014)